IGHG3 and COVID-19: The ratios did not statistically significantly differ between the sera of hospitalized and non-hospitalized D614G-infected patients (p = 0.55), indicating that COVID-19 disease severity is unlikely to have substantially influenced this IgG3/IgG ratio in this cohort.